Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.


Journal

Gene
ISSN: 1879-0038
Titre abrégé: Gene
Pays: Netherlands
ID NLM: 7706761

Informations de publication

Date de publication:
05 Oct 2020
Historique:
received: 25 02 2020
revised: 25 05 2020
accepted: 03 07 2020
pubmed: 11 7 2020
medline: 28 8 2020
entrez: 11 7 2020
Statut: ppublish

Résumé

HOX genes are important regulatory genes patterning head formation, including development of the ear. Microtia is a congenital ear anomaly characterized by lacking all or part of the structures of the outer ear. To date, only four HOXA2 mutations were reported in families with autosomal-recessive or dominant microtia, with or without hearing impairment. More identified mutations are needed to confirm the correlation between genotype and phenotype. Here, we collect two Chinese families with non-syndromic bilateral microtia. Next generation sequencing identified two heterozygous nonsense HOXA2 mutations, one in each family. One mutation (c.637A > T, p.Lys213*) is newly reported, while the other one (c.703C > T,p.Gln235*) is consistent with a previous report. In mouse, Hoxa2 can bind to a long-range enhancer and regulate expression of the Hmx1 gene, which is a crucial transcription factor in eye and ear development. Using dual luciferase reporter assays, we showed that both HOXA2 mutations have impaired activation of the long-range enhancer of HMX1. In the present study, we report the first two bilateral non-syndromic microtia cases with HOXA2 mutations of Chinese origin and identify a novel mutation. Our results also provide molecular insights about how these nonsense HOXA2 mutations could affect the activation of its downstream target HMX1 by interacting with the long-range enhancer.

Identifiants

pubmed: 32649979
pii: S0378-1119(20)30614-4
doi: 10.1016/j.gene.2020.144945
pii:
doi:

Substances chimiques

HOXA2 protein, human 0
Homeodomain Proteins 0
RNA, Messenger 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

144945

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Nuo Si (N)

Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China; Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, China.

Xiaolu Meng (X)

Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, China.

Xiaosheng Lu (X)

Department of Plastic Surgery, Affiliated Hospital of Weifang Medical University, China.

Xuelian Zhao (X)

Department of Plastic Surgery, The Second Hospital of Hebei Medical University, China.

Chuan Li (C)

Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China.

Meirong Yang (M)

Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China.

Ye Zhang (Y)

Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China.

Changchen Wang (C)

Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China.

Peipei Guo (P)

Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China.

Xue Zhang (X)

Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, China.

Bo Pan (B)

Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China. Electronic address: 13810855912@163.com.

Haiyue Jiang (H)

Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China. Electronic address: haiyuejiang2019@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH